ALT-711 Alagebrium chloride 341028-37-3

Min.Order / FOB Price:Get Latest Price

1 Gram	FOB Price: USD 1.0000

1 Gram

FOB Price: USD 1.0000

Min.Order :1 Gram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram,Other

Keywords

341028-37-3 ALT-711 Alagebrium chloride

Quick Details

Appearance:white powder
Application:pharmaceutical
PackAge:confirms to customer
ProductionCapacity:1|Kilogram|Day
Storage:shade
Transportation:confirms to customer

Superiority:

Alagebrium (formerly known as ALT-711) was a drug candidate developed by Alteon Corporation. It was the first drug candidate to be clinically tested for the purpose of breaking the crosslinks caused by advanced glycation endproducts(AGEs), thereby reversing one of the main mechanisms of aging.^[1] Through this effect Alagebrium is designed to reverse the stiffening of blood vessel walls that contributes to hypertension and cardiovascular disease, as well as many other forms of degradation associated with protein crosslinking.^[2]^[3]^[4] Alagebrium has proven effective in reducing systolic blood pressure^[5]and providing therapeutic benefit for patients with diastolic heart failure.^[6]

Details:

Alagebrium (formerly known as ALT-711) was a drug candidate developed by Alteon Corporation. It was the first drug candidate to be clinically tested for the purpose of breaking the crosslinks caused by advanced glycation endproducts(AGEs), thereby reversing one of the main mechanisms of aging.^[1] Through this effect Alagebrium is designed to reverse the stiffening of blood vessel walls that contributes to hypertension and cardiovascular disease, as well as many other forms of degradation associated with protein crosslinking.^[2]^[3]^[4] Alagebrium has proven effective in reducing <a medicine)"="" title="Systole (medicine)" style="margin: 0px auto; padding: 0px; font-family: sans-serif; font-size: 14px; border: 0px; color: rgb(11, 0, 128); line-height: 22px; background-image: none; background-color: rgb(250, 250, 250);">systolic blood pressure^[5]and providing therapeutic benefit for patients with diastolic heart failure.^[6]